Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: oral

Currently viewing:

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: The study is comparable to OECD Guideline 401 with acceptable restrictions (partly limited documentation, e.g. no details about the test substance; results presented only for males and females combined).

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1972
Report date:
1972

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 401 (Acute Oral Toxicity)
Deviations:
no
GLP compliance:
no
Test type:
standard acute method
Limit test:
no

Test material

Constituent 1
Reference substance name:
monomethylformamide
IUPAC Name:
monomethylformamide
Details on test material:
no further details

Test animals

Species:
rat
Strain:
Sprague-Dawley
Sex:
male/female
Details on test animals or test system and environmental conditions:
Source: SPF-Zucht der Firma Gassner, Sulzfeld, Germany
certified diet and water ad libitum
No further details.

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
water
Details on oral exposure:
concentration in test solution 20% at dose levels between 1600 and 2500 mg/kg bw; concentration 30% for >= 3200 mg/kg bw; no data about fasting prior to application.

Doses:
1600, 2000, 2500, 3200, 4000, 5000 mg/kg bw
No. of animals per sex per dose:
5 males and 5 females per dose
Control animals:
no
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations:daily
- weighing: no data
- Necropsy of survivors and rats found dead
Statistics:
LD50 calculated according to LITCHFIELD and WILCOXON.

Results and discussion

Effect levels
Sex:
male/female
Dose descriptor:
LD50
Effect level:
3 000 mg/kg bw
95% CL:
2 460 - 3 660
Remarks on result:
other: for males and females combined
Mortality:
Data on mortality are presented in the Table below. At the high dose levels rats died within 7 days and in a few cases also in the 2nd week.
Clinical signs:
other: Clinical signs: apathy, poor general condition, red encrusted noses; no effects seen in survivors after 6-12 days
Gross pathology:
Surviving rats: no treatment related effects.
Rats found dead: no treatment related effects.
Other findings:
no data

Any other information on results incl. tables

Acute toxicity in rats after oral application of monomethylformamide

Dose in mg/kg bw

Number of rats which died within

1 hour

24 hours

48 hours

7 days

14 days

5000

0/10

0/10

0/10

5/10

8/10

4000

0/10

0/10

0/10

5/10

6/10

3200

0/10

0/10

0/10

1/10

7/10

2500

0/10

0/10

0/10

1/10

2/10

2000

0/10

0/10

0/10

0/10

0/10

1600

0/10

0/10

0/10

0/10

0/10

Applicant's summary and conclusion

Conclusions:
The oral LD50 is 3000 mg/kg bw in male and female rats combined.
Executive summary:

The study is comparable to OECD Guideline 401 with acceptable restrictions (partly limited documentation, e.g. no details about the test substance; results presented only for males and females combined).

Groups of 5 male and 5 female rats were gavaged with 20 -30% aqueous solutions at dose levels of 1600, 2000, 2500, 3200, 4000, 5000 mg/kg bw. The post exposure observation period was 14 days. At the high dose levels rats died within 7 days and in a few cases also in the 2nd week.Clinical signs like apathy, poor general condition, and red encrusted noses occurred; no effects were seen in survivors after 6 -12 days. Necropsy revealed no treatment related effects.

Conclusion: The oral LD50 is 3000 mg/kg bw in male and female rats combined.